


Nucleix
Biotechnology Research • Rehovot, Merkaz 76000, Israel • 51-100 Employees
Company overview
| Headquarters | Rehovot, Merkaz 76000, Israel |
| Phone number | +97289161616 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Lung Cancer, Cancer Diagnostics, Bladder Cancer, Early Detection |
| Founded | 2008 |
| Employees | 51-100 |
| Socials |
Key Contacts at Nucleix
Adam Wasserstrom
Co-Founder, Vp Software & Analytics
Lisa Mcmahon
Senior Director Customer Excellence
Danny Frumkin
Co-Founder, Vp Research
John Stillwagen
Executive Director Information Technology
טל גדיש Tal Gadish
Director Of Software
Dov Terkieltaub
Senior Director Product Development
Vered Yayon
Director Of Clinical Operations
Anna Miller
Director Of Quality Assurance
Larry Johnson
Director, Laboratory Operations
Nucleix Email Formats
Nucleix uses 5 email formats. The most common is {first initial} (e.g., j@nucleix.com), used 67.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@nucleix.com | 67.2% |
{first name} | john@nucleix.com | 19% |
{first name}{last name} | johndoe@nucleix.com | 5.2% |
{first initial}.{last name} | j.doe@nucleix.com | 3.4% |
{first initial}{last name} | jdoe@nucleix.com | 1.7% |
About Nucleix
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. Our non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for physicians, their patients and the healthcare system. Our first product, Bladder EpiCheck®, is CE-marked in Europe for primary and recurrent bladder and upper tract urinary cancer, and FDA 510(k) cleared in the U.S. for bladder cancer recurrence. It is commercially available in both regions. Our global team operates from San Diego, California in the US and Rehovot, Israel.
Nucleix revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $145,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $32,000,000 |
| Total funding | $22,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Nucleix has 38 employees across 10 departments.
Departments
Number of employees
Nucleix Tech Stack
Discover the technologies and tools that power Nucleix's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Webmail
Miscellaneous
Programming languages
Blogs
CRM
Analytics
Frequently asked questions
4.8
40,000 users



